.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Ipratropium bromide - Generic Drug Details

« Back to Dashboard
Ipratropium bromide is the generic ingredient in three branded drugs marketed by Bausch And Lomb, Pharmascience Inc, Actavis Mid Atlantic, Teva Pharms Usa, Boehringer Ingelheim, Apotex Inc, Aurobindo Pharma Ltd, Mylan Speclt, Nephron, Roxane, Landela Pharm, Watson Labs, and Ritedose Corp, and is included in twenty-five NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has fifty-two patent family members in thirty-seven countries.

There are seven drug master file entries for ipratropium bromide. Twenty-one suppliers are listed for this compound.

Summary for Generic Name: ipratropium bromide

Tradenames:3
Patents:3
Applicants:13
NDAs:25
Drug Master File Entries: see list7
Suppliers / Packaging: see list21
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: ipratropium bromide

Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim
ATROVENT
ipratropium bromide
SPRAY, METERED;NASAL020393-001Oct 20, 1995RXYes► subscribe► subscribe
Apotex Inc
IPRATROPIUM BROMIDE
ipratropium bromide
SOLUTION;INHALATION075441-001Mar 28, 2001DISCNNo► subscribe► subscribe
Mylan Speclt
IPRATROPIUM BROMIDE
ipratropium bromide
SPRAY, METERED;NASAL075552-001Mar 31, 2003RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ipratropium bromide

These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim
ATROVENT HFA
ipratropium bromide
AEROSOL, METERED;INHALATION021527-001Nov 27, 20045,766,573► subscribe
Boehringer Ingelheim
ATROVENT HFA
ipratropium bromide
AEROSOL, METERED;INHALATION021527-001Nov 27, 20045,695,743► subscribe
Boehringer Ingelheim
ATROVENT
ipratropium bromide
SPRAY, METERED;NASAL020393-001Oct 20, 19954,385,048► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ipratropium bromide

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)0073170► subscribe
European Patent Office1413528► subscribe
Germany50009558► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc